Open AccessDeficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in A lzheimer's Disease
Author(s) -
Sengillo Jesse D.,
Winkler Ethan A.,
Walker Corey T.,
Sullivan John S.,
Johnson Mahlon,
Zlokovic Berislav V.
Publication year - 2013
Publication title -
brain pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.986
H-Index - 132
eISSN - 1750-3639
pISSN - 1015-6305
DOI - 10.1111/bpa.12004
Subject(s) - mural cell , blood–brain barrier , disease , mural , neuroscience , medicine , pathology , biology , central nervous system , vascular smooth muscle , smooth muscle , history , painting , art history
Neurovascular dysfunction contributes to A lzheimer's disease ( AD ). Cerebrovascular abnormalities and blood–brain barrier ( BBB ) damage have been shown in AD . The BBB dysfunction can lead to leakage of potentially neurotoxic plasma components in brain that may contribute to neuronal injury. Pericytes are integral in maintaining the BBB integrity. Pericyte‐deficient mice develop a chronic BBB damage preceding neuronal injury. Moreover, loss of pericytes was associated with BBB breakdown in patients with amyotrophic lateral sclerosis. Here, we demonstrate a decrease in mural vascular cells in AD , and show that pericyte number and coverage in the cortex and hippocampus of AD subjects compared with neurologically intact controls are reduced by 59% and 60% ( P < 0.01), and 32% and 33% ( P < 0.01), respectively. An increase in extravascular immunoglobulin G ( IgG ) and fibrin deposition correlated with reductions in pericyte coverage in AD cases compared with controls; the Pearson's correlation coefficient r for the magnitude of BBB breakdown to IgG and fibrin vs. reduction in pericyte coverage was −0.96 ( P < 0.01) and −0.81 ( P < 0.01) in the cortex, respectively, and −0.86 ( P < 0.01) and −0.98 ( P < 0.01) in the hippocampus, respectively. Thus, deficiency in mural vascular cells may contribute to disrupted vascular barrier properties and resultant neuronal dysfunction during AD pathogenesis.